Vanguard Group’s Icosavax, Inc. Common Stock ICVX Stock Holding History

Vanguard Group’s Portfolio ICVX Stock Details ICVX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-1,830,058	Closed	-$28.8M	–	4524
2023 Q4	$28.8M	Sell	1,830,058 -68,229	-4%	-$657K	﹤0.01%	2431
2023 Q3	$14.7M	Buy	1,898,287 +931,859	+96%	+$7.73M	﹤0.01%	2681
2023 Q2	$9.6M	Buy	966,428 +37,944	+4%	+$304K	﹤0.01%	2969
2023 Q1	$5.39M	Buy	928,484 +25,213	+3%	+$218K	﹤0.01%	3272
2022 Q4	$7.17M	Buy	903,271 +74,150	+9%	+$318K	﹤0.01%	3121
2022 Q3	$2.62M	Sell	829,121 -3,113	-0.4%	-$19.5K	﹤0.01%	3632
2022 Q2	$4.77M	Sell	832,234 -31,699	-4%	-$247K	﹤0.01%	3402
2022 Q1	$6.08M	Buy	863,933 +294,065	+52%	+$4.62M	﹤0.01%	3429
2021 Q4	$13M	Buy	569,868 +18,049	+3%	+$466K	﹤0.01%	3081
2021 Q3	$16.3M	Buy	+551,819	New	+$18.7M	﹤0.01%	2972

Vanguard Group's ICVX Position: Q1 2024 in Review

Vanguard Group sold out of Icosavax, Inc. Common Stock (ICVX) in Q1 2024, closing a stake of 1,830,058 shares — an estimated $28.8M sold.

Vanguard Group first reported a position in ICVX in Q3 2021 and held it in 10 quarters. The position peaked at $28.8M in Q4 2023. 0 funds tracked by Wall St. Rank hold ICVX as of Q1 2024.

Vanguard Group reported no remaining Icosavax, Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
Vanguard Group sold 1,830,058 Icosavax, Inc. Common Stock shares in Q1 2024, an estimated $28.8M.
Vanguard Group first reported a position in Icosavax, Inc. Common Stock in Q3 2021 and held it in 10 quarters.
Vanguard Group's Icosavax, Inc. Common Stock position peaked at $28.8M in Q4 2023.
0 funds tracked by Wall St. Rank held Icosavax, Inc. Common Stock as of Q1 2024.

Based on Vanguard Group's 13F filing for Q1 2024, filed 10 May 2024.